Xiaojiao W. Wang
127 Dongming Road
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical analysis of treatment free remission outcomes after discontinuation of tyrosine kinase inhibitors in childhood chronic myeloid leukemia
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: February 20, 2025
A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states.
Journal: Annals of translational medicine
Published: October 20, 2022
All-trans retinoic acid enhanced the antileukemic efficacy of ABT-199 in acute myeloid leukemia by downregulating the expression of S100A8.
Journal: International immunopharmacology
Published: April 12, 2022
The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia.
Journal: OncoTargets and therapy
Published: February 12, 2020
Significance of BCR-ABL fusion gene detection in CD34 (+) cells of chronic myelogenous leukemia patients
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 11, 2017
Clinical features and survival analysis of patients with CD56 expression in de- novo acute myeloid leukemia with t（8;21）
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 15, 2015
Inhibitory effect of thalidomide combined with interferon on the proliferation of Kasumi-1 cells
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 15, 2015
Clinical features and survival analysis of patients with CD20 positive adult B-lineage acute lymphoblastic leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: February 03, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026